Live Breaking News & Updates on Hugh Dickson

Stay updated with breaking news from Hugh dickson. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Recce Pharmaceuticals Announces Expansion of Phase I/II Trial of RECCE® 327 for the Treatment of Diabetic Foot Infections

Independent Safety Committee unanimously agrees that the Phase I/II trial is safe, well tolerated, and fit for expanded accessStudy achieving primary endpoints of safety, tolerability, and efficacy by resolving/curing bacterial infections in patients with diabetic foot ulcersRECCE® 327 dosed daily or every second day for 14 days is considered to be safe and well-toleratedAdditional clinical sites to be launched in Australia, and additional clinical trials will be launched internationally in diab ....

United States , New South Wales , James Graham , Andrew Geddes , Michael Fitzhugh , Guillaume Van Renterghem , Hugh Dickson , Recce Pharmaceuticals Ltd , Safety Committee , Safety Committee Of Liverpool Hospital , Lifesci Communications , Recce Pharmaceuticals , Independent Safety Committee , Pharmaceuticals Ltd , Liverpool Hospital , Professor Hugh Dickson , Ambulatory Care , Principal Investigator , Chief Executive Officer , New Class , Synthetic Anti Infectives , Infectious Disease Product , Generating Antibiotic Initiatives Now , Fast Track Designation , Pew Charitable Trusts Global New Antibiotics , Development Pipeline ,